Skip to main content
. 2019 Apr-Jun;10(2):232–238. doi: 10.4103/ccd.ccd_624_18

Table 3.

Intensity of E-cadherin immunostaining among the control and study groups

Description n Mean (per sample) SD F P
I Normal 10 2.9000 0.31623 31.108 <0.0001
II WDSCC 20 2.8000 0.41039
III MDSCC 20 2.3000 0.47016
IV PDSCC 17 1.5294 0.51450
Total 67 2.3433 0.68650

WDSCC: Well-differentiated squamous cell carcinoma; MDSCC: Moderately differentiated squamous cell carcinoma; PDSCC: Poorly differentiated squamous cell carcinoma; SD: Standard deviation